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CASE PRESENTATION
A 45-year-old-white woman with chronic kidney disease
stage V received a left radial-cephalic fistula in preparation
for renal replacement therapy. Her past medical history
was remarkable for hypertension, hypercholesterolemia,
and anemia. The social history was unremarkable. Her
medications included alteplase (5 mg/day), amlodipine
(10 mg/day), atorvastatin (10 mg/day), doxecalciferol
(0.25 mg), and erythropoietin a (20 000 U subcutaneously
every other week). Laboratory data are shown in Table 1.
Three months later the patient required renal replacement
therapy. Because the fistula was not considered adequate
for cannulation by the dialysis staff, she received a right
internal jugular-tunneled hemodialysis catheter to receive
dialysis therapy (3 h three times a week with a blood flow
rate of 360 ml/min). Six weeks later, the patient was
hospitalized with a febrile illness. Tunneled hemodialysis
catheter was removed and the patient fully recovered with
antibiotic therapy. She was discharged with a new
catheter. Two months later, the patient was referred for
difficulties during dialysis because of progressively
decreasing blood flow. Thrombolytic treatments failed to
correct the problem. Obliteration of the fibro-epithelial
sheath with catheter exchange was performed to provide
dialysis. At this point, the patient was referred to the
surgeon for arteriovenous fistula evaluation. Six weeks
later the patient was seen during rounds receiving
hemodialysis successfully through a right forearm
brachial-basilic loop graft. The arteriovenous fistula had
been abandoned.
CLINICAL DIAGNOSIS
The arteriovenous fistula (AVF) had failed to develop
adequately to support dialysis treatment in this patient.
The technical term that is used to describe this scenario is
‘early failure’ (commonly known as ‘immature fistula’).
CLINICAL FOLLOWUP
The clinical circumstances presented in the above-mentioned
case are not uncommon. In fact, most nephrologists in the
United States have been faced with similar clinical situations
on many occasions. Although the above-mentioned patient
received an AVF successfully, the access failed to mature
adequately to support dialysis treatment. In the interim, renal
replacement therapy was initiated using a tunneled hemo-
dialysis catheter. These devices are associated with frequent
hospitalization and serious complications, such as catheter-
related bacteremia, central venous stenosis, and catheter
dysfunction. The case presented here experienced at least one
episode of bacteremia requiring hospitalization. Examination
of the catheter exit-site demonstrated mild discharge. Blood
cultures were positive for methicillin-sensitive Staphylococcus
aureus. She made a full recovery and received a new catheter,
however subsequent development of catheter dysfunction
necessitated an invasive procedure. Although the AVF was
created successfully, a systematic followup including simple
physical examination to monitor the progress and matura-
tion of the access was not performed after the access
placement. Owing to the lack of familiarity with normal
and abnormal vascular access maturation processes, an
attempt to salvage the existing AVF was not made. The
fistula was abandoned and the patient received a graft.
DISCUSSION
Currently, AVF is considered to be the best available access
to provide hemodialysis therapy. However, a significant
number (28–53%) of fistulae fail to mature adequately to
support hemodialysis.1–3 It is anticipated that the efforts
of National Kidney Foundation and the Fistula First project
will increase the prevalence of AVF. In this context, AVF
failure to mature is likely to become more palpable.
This might further increase our reliance on catheters to
provide treatment to patients with fistulae that had not
matured to support dialysis therapy. This report provides
information on the most common causes and diagnosis of an
immature fistula. Most importantly, it calls for heightened
awareness of strategies to salvage fistulae with early failure
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instead of abandoning them in favor of an arteriovenous
graft.
EARLY AVF FAILURE
An AVF that does not mature adequately after creation to
support dialysis or fails within the first 3 months of its use
is said to have early failure.4 In general, a blood flow of
500 ml/min and a diameter of at least 4 mm are required for a
fistula to be adequate to support dialysis therapy.5 In most
successful fistulae, these parameters are achieved within
4–6 weeks.
Increments in blood flow and size begin to occur soon
after the construction of an AVF in a most of the cases6–14
(Figure 1). In addition to the blood flow augmentation in
newly created fistulae, recent studies have focused on the
changes in both blood flow and the diameter postopera-
tively.8,10–14 Recently, Robbin et al.14 found that major
changes in the fistula blood flow and size occurred rather
earlier on after fistula construction (diameter at 4
weeks¼B0.45 cm; blood flow at 4 weeks¼B700 ml/min),
and that the two variables were essentially the same during
the followup at 12 weeks (diameter¼B0.47 cm; blood
flow¼B675 ml/min). Most importantly, this study
(n¼ 69) determined the minimum venous diameter and
blood flow for predicting fistula outcomes. The results of the
study revealed that a minimum venous diameter of X0.4 cm
was associated with adequacy for dialysis in 67% of fistulae
and a blood flow rate ofX500 ml/min was associated with an
adequate fistula in 70% of cases. When both variables were
met, 95% of the fistulae were adequate for dialysis. In this
study, both a venous diameter of X0.4 cm and blood flow of
X500 ml/min were seen during the first 2 months. Of
particular interest, no significant changes in these two
parameters were noted in the second, third, or fourth month
after fistula creation.
In contrast, multiple reports have demonstrated that most
of the fistulae that did not achieve a significant increment in
the two parameters within the first 6–8 weeks failed to mature
adequately to support dialysis therapy 10–14 (Figure 1).
The above mentioned studies emphasize that a great
majority of fistulae that are going to mature will do so within
the first 2–4 weeks. In the case presented in this report, a
waiting period of 26 weeks elapsed before declaring that
fistula had failed to mature. Early intervention regarding
diagnosis and salvage of nonmaturing fistulae is critical for
several reasons. First, a fistula is the best available type of
access regarding complications, costs, morbidity, and mor-
tality. Second, this approach minimizes catheter use and its
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Figure 1 | Changes in blood flow and venous diameter in normal and early failure fistulae. (a) and (b) Changes in blood flow and diameter in
successful arteriovenous fistulae with time. (c) and (d) Changes in the two variables in fistulae with early failure. With permission from Asif et al.5
Table 1 | Laboratory data of the patient
White blood cell count 9.7
Hemoglobin 10.3
Hematocrit 31.3
Platelet count 288
Iron 44
Total iron-binding capacity 273
Ferritin 88
Calcium 9.0
Phosphate 4.8
Glucose 80
Sodium 138
Potassium 5.2
Chloride 101
Carbon dioxide 22
Blood urea nitrogen 68
Serum creatinine 5.2
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associated complications. Finally, access stenosis is a
progressive process and eventually culminates in complete
occlusion leading to access thrombosis. In this context, the
opportunity to salvage the fistula that fails early may be lost.
The index case received two tunneled dialysis catheters,
suffered from catheter-related bacteremia and fibro-epithelial
sheath before announcing fistula failure. These consequences
are serious and can result in death. It is for these reasons that
Fistula First recommends evaluation of a newly created fistula
at 4 weeks to determine its maturity.15
DIAGNOSIS OF FISTULAE WITH EARLY FAILURE
Fortunately, the identification of candidates with immature
fistulae is relatively simple. Ultrasonography can identify
successfully the candidates with immature fistulae. However,
this tool is not readily available in all centers and its use adds
to the cost of medical care. Recently, physical examination
has been highlighted to be a valuable tool in assessing fistulae
with early failure.3,4,16,17
Although failure of vascular (arterial and venous)
adaptation following arteriovenous access creation is an
important factor,5 Beathard et al.4 have emphasized the
presence of two most common causes of a fistula with early
failure (presence of stenosis and/or accessory veins) and
demonstrated that both can be diagnosed easily by physical
examination (Figure 2).16 The value of physical examination
in the identification of candidates with immature fistulae has
also been demonstrated by a recent report.3 In this
prospective study, 68 arteriovenous fistulae were created
and followed post-operatively by physical examination to
assess their developmental progress. After the resolution of
postoperative edema, physical examination was performed by
interventional nephrologists at 1- to 2-weeks. In this study,
24/68 (35%) fistulae failed to develop adequately to support
dialysis. All were identified by physical examination within 8
weeks of access creation.
Physical examination of the AVF is an important skill that
should be mastered by all nephrologists who manage dialysis
patients.16,17 The normal mature AVF has a soft pulse and is
easily compressible. There is a prominent thrill (hum and
buzz) at the anastomosis, which is present throughout the
entire structure during systole and diastole. When the
extremity is elevated, the fistula will generally collapse, at
least partially. Typically, with juxta-anastomotic stenosis, a
bounding pulse (water hammer) is felt at the anastomosis
and the thrill is diminished and shortened in duration
(Figure 2a). As one moves downstream from the anastomo-
sis, the pulse disappears at the site of the stenosis. Above this
level, the pulse is very weak and the vein is usually developed
poorly (Figure 2a). The strength of the pulse is directly
proportional to the arterial inflow pressure and is assessed by
the ‘pulse augmentation test’ (Figure 2b). Although a
subjective measure, this test can provide valuable informa-
tion regarding the strength of arterial inflow when performed
by an experienced examiner. It is performed by completely
occluding the access several centimeters downstream from
the arterial anastomosis and assessing the increment in the
volume of the pulse by palpation. A normal fistula augments
well, meaning it has a very strong pulse and by inference, a
good arterial inflow. In contrast, the fistula having a poor
arterial inflow will be found to augment poorly, meaning has
a weak pulse. Accessory veins can also be easily identified by
physical examination (Figure 2c). At times, they can be
diagnosed by visual inspection only. On other occasions,
examination by palpation is required to detect their presence.
Occlusion of the outflow of an AVF normally results in
disappearance of the thrill over the arterial anastomosis. If it
does not disappear, an accessory vein is present below the
point of occlusion. Palpation of the fistula below this point
will reveal the position of the accessory vein by the presence
of thrill over its trunk. Finally, with downstream stenosis, the
AVF becomes more forcefully pulsatile (hyperpulsatile) with a
discontinuous and predominantly systolic thrill. When the
extremity is elevated, the portion of the fistula distal to the
stenosis remains distended, whereas the proximal portion
collapses in the normal fashion.
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Figure 2 | Physical examination of an immature fistula. (a) Physical
examination of juxta-anastomotic stenosis: (A) Radial artery; (B) a
strong pulse is present at the anastomosis. The intensity of the thrill is
variable but generally diminished owing to decreased flow. The
fistula at this point may be dilated, at times almost aneurysmal.
(C) The pulse disappears as one moves up the fistula to the level
of the lesion. (b) Evaluation of pulse augmentation. The fistula is
first occluded completely at point A. The change in pulse intensity
(augmentation) is evaluated at point B. (c) Physical examination of
accessory vein. When the fistula is occluded at point A, the thrill will
disappear at the anastomosis (C). As the point of occlusion is moved
upward past the accessory vein (D) to point B, the thrill will continue
when the fistula is occluded because flow has an escape route. With
permission from Beathard.16
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Systematic physical examination in the evaluation of an
arteriovenous access is not performed routinely. From a
practical standpoint at a minimum, this evaluation should be
undertaken between 4 and 6 weeks by a skillful examiner. Any
fistula that fails to mature adequately and demonstrates
abnormal physical findings should be studied aggressively,
and abnormalities that are detected should be corrected
before a plan to create a new access is made.
SALVAGE OF FISTULAE WITH EARLY FAILURE
Once a patient with early fistula failure has been identified,
salvage of the fistula should be taken in a timely manner.
Early intervention to salvage a nonmaturing fistula is critical
for several reasons as mentioned above.
Recent data have emphasized that a most of these failed
fistulae can be successfully salvaged using percutaneous
techniques.3,4,18–20 In a prospective observational study,4 100
patients with early failure underwent evaluation and treat-
ment at six free-standing outpatient vascular access centers.
Vascular stenosis and the presence of a significant accessory
vein (an accessory vein is described as ‘a branch coming off
the main venous channel that comprised the fistula’) alone or
in combination were found to be the culprits in most
instances. Venous stenosis was present in 78% of the cases.
Most of these lesions (48%) were found to be close to the
anastomosis (a juxta-anastomotic lesion). A significant
accessory vein was present in 46% of the cases. Percutaneous
balloon angioplasty and accessory vein obliteration using
one of three techniques (percutaneous ligation using 3/0
nylon, venous cutdown, and coil insertion) were used to
salvage the failed fistulae. Angioplasty was performed with a
98% and vein obliteration with a 100% success rate. After
intervention, it was possible to initiate dialysis using the
fistula in 92% of the cases. Actuarial life-table analysis
showed that 84% were functional at 3 months, 72% at 6
months, and 68% at 12 months. The overall complication
rate in this series was 4%; of these 3% were minor and 1%
were major. All of these adverse events were associated with
angioplasty procedures. The single major complication
consisted of a vein rupture with an expanding hematoma.
It resulted in loss of the access. The three minor complica-
tions were all hematomas that required no treatment and had
no sequelae. Using a percutaneous ligation technique, a
separate report has also described accessory vein ligation of
AVFs that failed to achieve adequate blood flow or size for
successful cannulation.18 By using two basic techniques,
balloon angioplasty and vein obliteration, nephrologists can
successfully salvage and subsequently utilize an otherwise
failed fistula.
Surgical intervention can also be used to salvage an AVF
with early failure.21,22 The creation of a new anastomosis for
a juxta-anastomotic lesion and superficialization procedures
are some of the techniques that can be employed to salvage a
fistula. However, there is a lack of prospective studies
examining the role of surgical approach in the salvage of
fistulae with early failure only.
It is worth mentioning that the impact of preoperative
imaging on the subsequent incidence of early failure is
controversial. In one study where preoperative ultrasound
mapping was used, early failure was seen in only 8.3% (nine
of the 108 fistulae created) compared with 36% (six of the 26
fistulae created) when preoperative imaging was not
performed.23 In contrast, a recent study did not find
preoperative mapping to be helpful in reducing early failure.3
Despite preoperative venography, the incidence of early
failure was found to be 35% (24 of the 68 fistulae created).
However, the two studies did not use the same imaging
technique. In addition, the latter study included patients with
multiple previously failed accesses. Large-scale studies using
matching imaging techniques and patient population are
needed to settle the influence of preoperative vascular
mapping on early fistula failure.
SALVAGE PROCEDURES AND THE RISK OF
RADIOCONTRAST-INDUCED NEPHROPATHY
Although percutaneous interventions can salvage successfully
a significant number of fistulae with early failure, the
development of acute renal failure owing to the use of
radiocontrast medium is worth mentioning in patients with
advanced renal failure who have not yet initiated dialysis.
Recent data have emphasized that low dose of low-osmolar
contrast agent may be safer in patients with stages IV and V
chronic kidney disease (CKD).24,25 In a retrospective analysis,
Kian et al.24 reported on the incidence of radiocontrast-
induced nephropathy in 34 CKD stage-IV patients under-
going salvage procedures for nonmaturing fistulae. Radio-
contrast-induced nephropathy was defined as a 25% increase
in serum creatinine from the baseline value. Serum creatinine
was obtained pre, 2- and 7-days postcontrast administration.
In this study, the mean contrast volume was 7.8 ml per
procedure. The incidence of acute renal failure was 4% at 2
days and 4.6% at 1 week. All values returned to baseline
within 2 weeks. None of the patients required acute dialysis.
A separate study has also evaluated the safety of radiocontrast
medium in CKD stage IV and V patients.24 In this
prospective analysis, 25 consecutive patients (CKD stages
IV and V) undergoing venography for fistula creation were
enrolled. Radiocontrast-induced nephropathy was defined as
a 20% decrease in the estimated glomerular filtration rate
(GFR) from the baseline value at 48 h after contrast
administration. Venography was performed by using
10–20 cm3 of low-osmolarity contrast medium. Complete
sets of pre- and post-procedure glomerular filtration rates
were available in 21 patients. At 48 h, there were no
differences between the pre- and postprocedure glomerular
filtration rates. At 4 weeks of followup, only one patient
required dialysis owing to the development of flu-like
syndrome and ensuing volume depletion.
On the basis of these studies, dose limitation of a
radiocontrast agent is of paramount importance during
percutaneous interventions to salvage nonmaturing fistulae
in CKD stage IV and V patients, who have not yet initiated
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dialysis. Although these reports are encouraging, large-scale
studies with a longer follow-up are needed to establish
conclusively the safety of low dose in the development of
acute renal failure.
TEACHING POINTS
(1) A significant number of fistulae fail to develop adequately
to support dialysis after their successful creation. (2) A
systematic physical examination of the access at 4–6 weeks
after fistula creation provides a simple means for the
identification of patients with early fistula failure. (3) Basic
percutaneous techniques (angioplasty and accessory vein
obliteration) can successfully salvage a great majority of
fistulae with early failure.
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